U.S. Markets
TD Cowen raises global GLP-1 sales forecast to USD 150bln by 2030 (+ USD 139bln), driven by stronger demand for diabetes and obesity treatments
What do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
